Full-Time

Global Supply Planning Manager

Posted on 5/9/2026

Integer Holdings Corporation

Integer Holdings Corporation

1,001-5,000 employees

Medical device CDMO for cardiac devices

Compensation Overview

$94.5k - $138.6k/yr

+ Cash-based incentive program

Remote in USA + 1 more

More locations: Plano, TX, USA

Hybrid

Hybrid role; on-site in Plano, TX required; remote work allowed but not fully remote.

Category
Operations & Logistics (2)
,
Required Skills
Power BI
SAP Products
Tableau
Oracle
Data Analysis
Excel/Numbers/Sheets
Requirements
  • Bachelor’s degree in supply chain, Operations, Business, Finance, or similar technical discipline.
  • APICS CPIM certification desirable.
  • Master’s preferred.
  • 10+ years of experience in supply planning, operations planning, or integrated business planning, with a strong global or multi-site supply chain planning background.
  • Travel (approximately 15%) may be required.
  • Knowledge of supply planning systems, including capacity planning and constraint-based planning processes.
  • Strong capability in statistical analysis, modeling, and data visualization, with experience using tools such as advanced Excel, Power BI, and Tableau.
  • Experience with ERP and planning systems (SAP/Oracle preferred).
  • Experience working with large and complex data sets.
  • Proven success influencing cross-functionally at all levels and managing change.
  • Strong written and verbal communication skills.
  • Demonstrated problem-solving skills with the ability to translate data into clear recommendations.
  • Advanced computer and presentation skills.
  • Proven experience leading SIOP/IBP processes in complex, multi-site manufacturing environments.
Responsibilities
  • Adheres to Integer’s Values and all safety, environmental, security, and quality requirements including, but not limited to: Quality Management Systems (QMS); Safety, Environmental and Security Management Systems; regulatory requirements specific to the Company, site, and business; and Company policies and operating procedures.
  • Coordinates global supply planning efforts across 20+ manufacturing sites, driving the development of a global supply plan to support on-time, in-full delivery of customer demand and revenue plans.
  • Executes the SIOP cadence by aligning supply plans with unconstrained demand forecasts, financial goals, and operational constraints, identifying gaps and enabling timely decision-making.
  • Supports scenario planning and trade-off analysis to evaluate service, cost, and inventory impacts, and provides clear recommendations to senior leadership.
  • Develops and maintains constraint-based planning models and tools to improve agility and responsiveness.
  • Partners with site planning teams to implement standardized processes and ensure consistent execution.
  • Serves as a subject matter expert in planning forums, supporting alignment across Commercial, Operations, Procurement, Engineering, and Finance.
  • Identifies and recommends systemic enhancements to planning processes, data flows, and performance tracking (e.g., forecast consumption, capacity modeling, safety stock strategy).
  • Defines and drives key supply planning KPIs, tracking performance and leading actions to improve service, financial performance, and plan adherence.
  • Champions the use of advanced planning tools and analytics, transforming data into actionable recommendations and supporting adoption across sites.
  • Supports planning system implementations and digital transformation initiatives in collaboration with IT and Digital teams.
  • Provides analytical support for global supply management, including monthly and annual reporting, site and enterprise analyses, and risk/opportunity identification.
  • Develops and maintains training materials for supply planning processes and facilitates knowledge sharing across teams.
  • Performs other duties as required.
Desired Qualifications
  • APICS CPIM certification desirable.
  • Master’s preferred.
Integer Holdings Corporation

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Simplify Jobs

Simplify's Take

What believers are saying

  • Board initiated strategic review on April 30, 2026, exploring sale options.
  • Irenic Capital acquired $99M stake in Q4 2025 as top holding.
  • $200M share repurchase authorization signals management confidence in valuation.

What critics are saying

  • Class action lawsuits by Pomerantz and Bleichmar drain cash via settlements by Q4 2026.
  • Three new products cause 3-4% headwind, slashing H2 2026 margins.
  • Irenic activism forces sale at depressed valuation below $93 target in 12 months.

What makes Integer Holdings Corporation unique

  • Integer specializes in contract manufacturing for Cardio & Vascular medical devices.
  • Organic revenue grew 1.3% in Q1 2026 despite flat overall sales.
  • Robust pipeline targets above-market growth by 200 basis points in 2027.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Integer Holdings Corporation who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 24th, 2026
Integer VP sells $70K in shares as stock drops 28% in a year

Integer Holdings Corporation shares fell 28% following an insider sale disclosure. Tom Thomas, the company's vice president and corporate controller, sold 825 shares of common stock in an open-market transaction on 13 March 2026, according to an SEC Form 4 filing. The transaction was valued at $70,000 at a reported price of $85 per share. The sale represented 15.85% of Thomas's direct holdings at the time. Following the transaction, Thomas holds 4,380 shares worth approximately $364,000. This marks Thomas's third open-market sale since 2018, following previous sales of 884 shares in November and 1,500 shares in April. Integer Holdings manufactures medical devices and components, generating $1.85 billion in trailing twelve-month revenue.

Yahoo Finance
Feb 26th, 2026
Integer Holdings Q4 earnings beat forecasts on strong Cardio & Vascular demand

Integer Holdings, a medical device manufacturer, reported fourth quarter revenue of $472.1 million and adjusted earnings per share of $1.76, both exceeding analyst expectations. The company posted 5% year-on-year revenue growth, driven by strong performance in its Cardio & Vascular segment. CEO Peyman Khales attributed $30 million in operational improvements to higher sales volume, manufacturing efficiencies and expense management. The company guided adjusted earnings per share of $6.54 for 2026, beating analyst estimates by 3.8%. During the earnings call, analysts questioned the narrowing of organic sales guidance, first quarter margin compression and the company's path to above-market growth in 2027. Management emphasised collaborative customer planning and reaffirmed its current strategy despite activist investor involvement.

Intellectia.AI
Feb 23rd, 2026
Irenic Capital takes $99M stake in Integer Holdings as medical device firm posts 8% sales growth

Irenic Capital Management has acquired a $99.11 million stake in Integer Holdings, purchasing 1,263,663 shares in Q4 2026. The position represents 13.7% of Irenic's assets under management, making it the fund's largest disclosed equity holding. Integer Holdings, a medical device company, achieved 8% sales growth in 2025, reaching $1.85 billion in revenue, with adjusted earnings per share rising 21% to $6.40. The company reported fourth-quarter sales of $472 million and net income of $62 million, up 22% year-over-year. Management projects 2026 adjusted earnings per share between $6.29 and $6.78, with plans to achieve organic growth exceeding market rates by 200 basis points in 2027. Benchmark analyst Robert Wasserman upgraded the stock from hold to buy with a $95 price target.

Yahoo Finance
Feb 23rd, 2026
Integer posts 21% adjusted EPS growth but warns of H1 2026 headwinds from slower product adoption

Integer Holdings reported strong 2025 results with sales up 8% and adjusted earnings per share rising 21% to $6.40, alongside margin expansion and $105 million in free cash flow. The company returned capital through a $50 million share repurchase and announced an additional $50 million accelerated share repurchase programme. However, management warned that three newer products representing approximately 6% of 2025 sales are experiencing slower-than-expected adoption, creating a 3%–4% headwind for 2026. The company expects flat-to-slightly-down sales and a 200–250 basis point hit to first-quarter operating margin, with recovery and margin expansion anticipated in the second half. Integer maintained its 2026 midpoint guidance, with year-end net debt expected at $1.17–1.19 billion and net leverage remaining at 3.0 times adjusted EBITDA.

Yahoo Finance
Feb 19th, 2026
Integer faces 2026 headwinds from delayed product launches despite $200M buyback and robust pipeline

Integer Holdings, a medical device contract manufacturing organisation, reported fourth-quarter sales of $472 million, up 5% year-over-year, with adjusted earnings per share at the high end of its October guidance range. For the full year 2025, sales increased 8% on a reported basis and over 6% organically, whilst adjusted operating income rose 13%. The company issued 2026 guidance expecting reported sales to be down 1% to up 1%, with a 3% to 4% headwind from three new products facing lower-than-expected market adoption. However, Integer's underlying business is expected to grow 4% to 6%, in line with the market. Integer repurchased $50 million of shares in Q4 and announced plans for an additional $50 million accelerated share repurchase programme under its $200 million authorisation.